Gujarat State Fertilizers & Chemicals Ltd Q4 FY2022 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/34y9bvwqxfpsfnijd9zw6tv7.pdf

Key Takeaways


FY22 Performance: The Peak and Its Drivers

Nanavaty: "I am glad to announce that this was the record year for GSFC in terms of highest sales in revenue terms and highest PBT and PAT in the history of the company."

Margin Outlook: Normalization After an Abnormal Year

Nanavaty: "FY2022, because of the COVID effect it was a kind of an abnormal year, abnormally good for the company, as I said we look forward to a normal margin between 5% and 10% in fertilizer and between 10% to 15% in chemical, so that would be the kind of performance in current financial year."

Project Pipeline: De-risking Through Chemical Expansion

Nanavaty: "Broadly we will be confining ourselves to our niche areas or core strength and we do not want to venture into unknown areas..."

Raw Material & Cost Environment


Capital Allocation & Balance Sheet

Nanavaty: "As you know GSFC is a conservative company, so we will not jump suddenly of higher dividend because of good numbers and one would expect that dividend should be consistent..."

Demand & Competitive Position


Guidance & Commitments

CommitmentSpecificsTimeline
Revenue growth"Maybe 25% growth" for FY23FY23
FY23 revenue targetCrossing ₹11,000 Crores (from ~₹9,000 Cr in FY22)FY23
Industrial margin normalizationDip seen in Q4 to normalizeQ1 FY23
Normal margin range5%-10% in fertilizer, 10%-15% in chemicalsFY23 (sustainable)
Capro-benzene spreadMinimum $1000 spread maintained on overall basisOngoing
Capex spendAround ₹400 CroresFY23
Sulphuric acid plant (Baroda)600 MTPD, ~₹250 Cr capexCommissioning 2024
Ammonium sulphate fourth plant400 MT capacity, ₹110 Cr capex, ~₹480 Cr annual revenueCommissioning by next year-end
HX crystal plant20 MTPD, ₹125 Cr capex, ~₹100 Cr turnoverCommissioning by end of next year
Solar project15 MW, reduce power costCommissioning by December 2022
Potash project updateAnnouncement on project movementExpected around July 2022
Phosphoric acid price increaseMinimum 15% to 30% increase expectedPending OCP declaration

Key Metrics

MetricQ4 FY22
Revenue₹9,000 cr (FY22 full year), +20% YoY; industrial product sales +65% YoY
Revenue guidance₹11,000 cr expected for FY23, +25% YoY
Industrial products margin9% in Q4 (profit ₹68 cr on sales ₹782 cr), down from ~25% in Q3 (profit ₹166 cr on sales ₹687 cr)
Normalized industrial products margin12% to 15% expected going forward
Fertilizer segment margin5% to 10% sustainable; Q4 profitability elevated due to one-time subsidy differential claims
Chemical segment margin10% to 15% normal margin
Caprolactam benzene spread~$1,000, improved from ~$700 last year; maintainable
Employee cost₹668 cr (full year FY22); some inflation impact expected in FY23
Inventory increase₹319 cr, driven by valuation increase from peak raw material prices in Q4, not volume
Nylon-6 production vs sales7,106 tons produced, 1,541 tons sold; Caprolactam diverted to Nylon-6 value chain
Dividend payout11% of earnings; management cites conservative policy and capex funding needs
Subsidy pending₹75 cr on balance sheet; phosphatic subsidy received up to March 2022, urea up to April 2022
FY23 capex plan₹400 cr planned spend
Revenue addition from near-term capex₹500 cr to ₹600 cr minimum additional from HX crystal and ammonium sulphate plants by end-FY24
Ammonium sulphate market shareMore than 60% currently; expected to increase with fourth plant
Potash contract price (India 2022)$590, up from $280 in 2021; business case for reviving potash project
Green energy share40% to 45% of total energy use